PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport.

The chloroquine resistance transporter (PfCRT) confers resistance to a wide range of quinoline and quinoline-like antimalarial drugs in Plasmodium falciparum, with local drug histories driving its evolution and, hence, the drug transport specificities. For example, the change in prescription practic...

Full description

Bibliographic Details
Main Authors: Guillermo M Gomez, Giulia D'Arrigo, Cecilia P Sanchez, Fiona Berger, Rebecca C Wade, Michael Lanzer
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-06-01
Series:PLoS Pathogens
Online Access:https://doi.org/10.1371/journal.ppat.1011436
_version_ 1797736198080299008
author Guillermo M Gomez
Giulia D'Arrigo
Cecilia P Sanchez
Fiona Berger
Rebecca C Wade
Michael Lanzer
author_facet Guillermo M Gomez
Giulia D'Arrigo
Cecilia P Sanchez
Fiona Berger
Rebecca C Wade
Michael Lanzer
author_sort Guillermo M Gomez
collection DOAJ
description The chloroquine resistance transporter (PfCRT) confers resistance to a wide range of quinoline and quinoline-like antimalarial drugs in Plasmodium falciparum, with local drug histories driving its evolution and, hence, the drug transport specificities. For example, the change in prescription practice from chloroquine (CQ) to piperaquine (PPQ) in Southeast Asia has resulted in PfCRT variants that carry an additional mutation, leading to PPQ resistance and, concomitantly, to CQ re-sensitization. How this additional amino acid substitution guides such opposing changes in drug susceptibility is largely unclear. Here, we show by detailed kinetic analyses that both the CQ- and the PPQ-resistance conferring PfCRT variants can bind and transport both drugs. Surprisingly, the kinetic profiles revealed subtle yet significant differences, defining a threshold for in vivo CQ and PPQ resistance. Competition kinetics, together with docking and molecular dynamics simulations, show that the PfCRT variant from the Southeast Asian P. falciparum strain Dd2 can accept simultaneously both CQ and PPQ at distinct but allosterically interacting sites. Furthermore, combining existing mutations associated with PPQ resistance created a PfCRT isoform with unprecedented non-Michaelis-Menten kinetics and superior transport efficiency for both CQ and PPQ. Our study provides additional insights into the organization of the substrate binding cavity of PfCRT and, in addition, reveals perspectives for PfCRT variants with equal transport efficiencies for both PPQ and CQ.
first_indexed 2024-03-12T13:09:12Z
format Article
id doaj.art-4dfce052391d4bef93bf212ea18e6e8b
institution Directory Open Access Journal
issn 1553-7366
1553-7374
language English
last_indexed 2024-03-12T13:09:12Z
publishDate 2023-06-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj.art-4dfce052391d4bef93bf212ea18e6e8b2023-08-28T05:30:42ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742023-06-01196e101143610.1371/journal.ppat.1011436PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport.Guillermo M GomezGiulia D'ArrigoCecilia P SanchezFiona BergerRebecca C WadeMichael LanzerThe chloroquine resistance transporter (PfCRT) confers resistance to a wide range of quinoline and quinoline-like antimalarial drugs in Plasmodium falciparum, with local drug histories driving its evolution and, hence, the drug transport specificities. For example, the change in prescription practice from chloroquine (CQ) to piperaquine (PPQ) in Southeast Asia has resulted in PfCRT variants that carry an additional mutation, leading to PPQ resistance and, concomitantly, to CQ re-sensitization. How this additional amino acid substitution guides such opposing changes in drug susceptibility is largely unclear. Here, we show by detailed kinetic analyses that both the CQ- and the PPQ-resistance conferring PfCRT variants can bind and transport both drugs. Surprisingly, the kinetic profiles revealed subtle yet significant differences, defining a threshold for in vivo CQ and PPQ resistance. Competition kinetics, together with docking and molecular dynamics simulations, show that the PfCRT variant from the Southeast Asian P. falciparum strain Dd2 can accept simultaneously both CQ and PPQ at distinct but allosterically interacting sites. Furthermore, combining existing mutations associated with PPQ resistance created a PfCRT isoform with unprecedented non-Michaelis-Menten kinetics and superior transport efficiency for both CQ and PPQ. Our study provides additional insights into the organization of the substrate binding cavity of PfCRT and, in addition, reveals perspectives for PfCRT variants with equal transport efficiencies for both PPQ and CQ.https://doi.org/10.1371/journal.ppat.1011436
spellingShingle Guillermo M Gomez
Giulia D'Arrigo
Cecilia P Sanchez
Fiona Berger
Rebecca C Wade
Michael Lanzer
PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport.
PLoS Pathogens
title PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport.
title_full PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport.
title_fullStr PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport.
title_full_unstemmed PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport.
title_short PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport.
title_sort pfcrt mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport
url https://doi.org/10.1371/journal.ppat.1011436
work_keys_str_mv AT guillermomgomez pfcrtmutationsconferringpiperaquineresistanceinfalciparummalariashapethekineticsofquinolinedrugbindingandtransport
AT giuliadarrigo pfcrtmutationsconferringpiperaquineresistanceinfalciparummalariashapethekineticsofquinolinedrugbindingandtransport
AT ceciliapsanchez pfcrtmutationsconferringpiperaquineresistanceinfalciparummalariashapethekineticsofquinolinedrugbindingandtransport
AT fionaberger pfcrtmutationsconferringpiperaquineresistanceinfalciparummalariashapethekineticsofquinolinedrugbindingandtransport
AT rebeccacwade pfcrtmutationsconferringpiperaquineresistanceinfalciparummalariashapethekineticsofquinolinedrugbindingandtransport
AT michaellanzer pfcrtmutationsconferringpiperaquineresistanceinfalciparummalariashapethekineticsofquinolinedrugbindingandtransport